3 Stocks We're Watching in the First Quarter

3 Stocks We're Watching in the First Quarter


The first-quarter of 2017 is already chock-full of weighty news events and potential catalysts that have investors' collective heads spinning. So while it may be tough to concentrate with so much going on, our Foolish contributors think that Bristol-Myers Squibb : Bristol-Myers Squibb's shares have now lost approximately 33% of their value from their former 52-week high.



from Biotech News